Case Studies
Optimising post approval research
A large global pharma company was required to run a complex global safety study by the regulatory authorities. This was
December 14, 2023
Menu
A large global pharma company was required to run a complex global safety study by the regulatory authorities. This was
Baseline Plus provided the ideal platform to enable a specialised European Pharma company to run a post approval safety study
Cisiv’s electronic data capture (EDC) platform, Baseline Plus, is built specifically to meet the complex needs of post-approval research. Its
A leading global pharmaceutical company was looking for a fit-for-purpose technology and methodology to evaluate the effectiveness of an anti-psychotic
Pregnancy registries gather health information from women who take prescription medicines or vaccines when pregnant and compare it to data
Expanded Access Programs (EAPs), sometimes known as Managed Access Programmes (MAPs), allow pharmaceutical sponsors to offer patients their pre-approval investigational
This joint blog between Cisiv and Boyds discusses the strategic reasons for collecting real world data (RWD) alongside expanded access
Get in touch today to speak to one of our expert team and find out how we can help you with your study.
© Copyright Cisiv 2024 | Registered Company Number: 3110147
© Copyright Cisiv
To find out more about the Cisiv technology and how we can help you with your study.